FDA approves Esbriet and Ofev in the U.S. as treatment for idiopathic pulmonary fibrosis Medicine & Technology Oct 16, 2014 FDA approves the selling of Esbriet and Ofev in the U.S. as treatment for idiopathic pulmonary fibrosis.
TECH & INNOVATION OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts